Evaluation of a fecal occult blood test with reverse passive hemagglutination for colorectal neoplasm screening

doi:10.3748/wjg.v3.i1.38

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2637)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-6) series.

Item

Count

PDF

252

HTML

2146

Tables (1-6)

239

Sum=2637

Mar 15, 1997 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Research

World J Gastroenterol. Mar 15, 1997; 3(1): 38-40
Published online Mar 15, 1997. doi: 10.3748/wjg.v3.i1.38

Table 1 Relationship between the 1^st reverse passive hemagglutination fecal occult blood test and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	60	250	Total	310
RPHA FOBT	-	380	1863	2243
Total		440	2113	2553

Sensitivity: 13.6% (60/440), specificity: 88.2% (1863/2113), positive predictive value: 16.1% (60/310), negative predictive value: 83.1% (1863/2243).

Table 2 Relationship between the 2^nd reverse passive hemagglutination fecal occult blood test and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	50	168	Total	236
RPHA FOBT	-	372	1823	2195
Total		422	2009	2431

Sensitivity: 11.8% (50/422), specificity: 90.7% (1823/2009), positive predictive value: 21.2% (50/236), negative predictive value: 83.1% (1823/2195).

Table 3 Relationship between the 3^rd reverse passive hemagglutination fecal occult blood test and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	55	151	Total	206
RPHA FOBT	-	333	1733	2066
Total		388	1884	2272

Sensitivity: 14.2% (55/388), specificity: 92.0% (1733/1884), positive predictive value: 26.7% (55/206), negative predictive value: 83.9% (1773/2066).

Table 4 Relationship between three sampling 1/3 (+) and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	85	346	Total	431
RPHA FOBT	-	302	1539	1841
Total		387	1885	2272

Sensitivity: 22.0% (85/387), specificity: 81.6% (1539/1885), positive predictive value: 19.7% (85/431), negative predictive value: 83.6% (1539/1841).

Table 5 Relationship between three sampling 2/3 (+) and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	46	138	Total	184
RPHA FOBT	-	341	1747	2088
Total		387	1885	2272

Sensitivity: 11.9% (46/341), specificity: 92.7% (1747/1885), positive predictive value: 25.0% (46/184), negative predictive value: 83.7% (1747/2088).

Table 6 Relationship between three sampling 3/3 (+) and colorectal neoplasm

		Colorectal neoplasm		Total
		+	-
RPHA FOBT	+	21	66	Total	87
RPHA FOBT	-	366	1819	2185
Total		387	1885	2272

Sensitivity: 5.4% (21/387), specificity: 96.5% (1819/1885), positive predictive value: 24.1% (21/87), negative predictive value: 83.2% (1819/2185)

Citation: Zhou L, Yu H, Zheng S. Evaluation of a fecal occult blood test with reverse passive hemagglutination for colorectal neoplasm screening. World J Gastroenterol 1997; 3(1): 38-40
URL: https://www.wjgnet.com/1007-9327/full/v3/i1/38.htm
DOI: https://dx.doi.org/10.3748/wjg.v3.i1.38